Read + Share
Amedeo Smart
Independent Medical Education
Ito Y, Shimono J, Kawamoto K, Hatanaka KC, et al. TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma. Leukemia 2025 May 2. doi: 10.1038/s41375-025-02631.PMID: 40316697
Email
LinkedIn
Privacy Policy